The general mood among these heavyweight investors is divided, with 50% leaning bullish and 50% bearish. Among these notable ...

We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we ...

Considering Botox for migraine but wondering if it'll change your face? Discover what it can and can't do, plus learn about potential side effects, benefits, and outcomes.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with ...

AbbVie (ABBV) stock price has done well this year as it surged to a record high of $200. It has jumped by more than 32% this ...

On 30 March, the FDA accepted AbbVie’s new drug application (NDA) for atogepant for the preventive treatment of migraine.

Dividend stocks can offer a fantastic way to magnify your returns with time and offer additional cash to reinvest or keep on ...

Three Motley Fool contributors believe they have identified magnificent dividend stocks to buy in October -- and all of them are drugmakers. Here's why they picked AbbVie ( ABBV -0.59%), Amgen ( AMGN ...

AbbVie Inc. (NYSE:ABBV) is well-positioned to deliver a top-tier long-term outlook, driven by Humira’s success and strategic ...

How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...